Human serum amyloid A protein inhibits hepatitis C virus entry into cells

Zhaohui Cai, Lei Cai, Jieyun Jiang, Kyung Soo Chang, Deneys R. Van Der Westhuyzen, Guangxiang Luo

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Abstract

Serum amyloid A (SAA) is an acute-phase protein induced by a variety of inflammatory stimuli, including bacterial and viral infections. SAA was recently found to function as an opsonin for gram-negative bacteria. We report here that SAA inhibited hepatitis C virus (HCV) infection in cultured cells. SAA reduced HCV infectivity in a dose-dependent manner when added during HCV infection but not after virus entry. SAA bound HCV virions and specifically blocked HCV entry but did not affect virus attachment. These findings suggest that SAA functions as part of the host innate immune defense mechanisms against HCV infection in humans.

Original languageEnglish
Pages (from-to)6128-6133
Number of pages6
JournalJournal of Virology
Volume81
Issue number11
DOIs
StatePublished - Jun 2007

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Fingerprint

Dive into the research topics of 'Human serum amyloid A protein inhibits hepatitis C virus entry into cells'. Together they form a unique fingerprint.

Cite this